Compres i vendes de directius (Form 4)

Directius de BELITE BIO, INC: compres i vendes · BLTE

Consellers, directius i accionistes de més del 10% han de declarar a la SEC cada compra i cada venda d'accions de la seva empresa en dos dies hàbils. Operacions declarades entre el 2026-09-04 i el 2026-10-01. Totes les declaracions a SEC EDGAR →

Comprat
0 $
Venut
31.968.735 $
Compres
0
Vendes
46

Les 46 operacions

DataQuiCàrrecOperació AccionsPreuImport
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 200 163,62 32.725 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 120 165,49 19.859 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 78 167,59 13.072 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 50 166,44 8.322 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 24 164,64 3.951 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 14 169,36 2.371 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 12 168,21 2.019 $
2026-10-01Scholl Hendrik Peter Chief Medical Officer venda 2 170,02 340 $
2026-09-08Lin Yu-Hsin Chief Executive Officer venda 8.752 197,36 1.727.275 $
2026-09-08Lin Yu-Hsin Chief Executive Officer venda 6.090 195,62 1.191.325 $
2026-09-08Lin Yu-Hsin Chief Executive Officer venda 6.058 196,54 1.190.642 $
2026-09-08Chuang Hao-Yuan Chief Financial Officer venda 4.605 197,23 908.244 $
2026-09-08Chuang Hao-Yuan Chief Financial Officer venda 4.475 196,47 879.200 $
2026-09-08Chuang Hao-Yuan Chief Financial Officer venda 4.120 195,60 805.889 $
2026-09-08Lin Yu-Hsin Chief Executive Officer venda 2.700 198,09 534.845 $
2026-09-08Chuang Hao-Yuan Chief Financial Officer venda 2.562 198,05 507.392 $
2026-09-08Lin Yu-Hsin Chief Executive Officer venda 2.400 194,33 466.399 $
2026-09-08Chuang Hao-Yuan Chief Financial Officer venda 2.200 194,28 427.414 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 11.080 191,15 2.117.909 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 8.955 189,34 1.695.552 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 8.111 193,13 1.566.439 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 7.800 186,32 1.453.323 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 6.200 191,09 1.184.754 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 6.200 189,22 1.173.191 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 6.200 187,25 1.160.964 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 6.252 184,52 1.153.647 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 4.955 183,30 908.228 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 4.602 193,12 888.727 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 4.600 186,34 857.187 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 4.593 185,34 851.286 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 4.209 192,54 810.412 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 3.900 187,16 729.942 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 3.872 185,28 717.408 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 3.759 183,27 688.899 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 3.569 184,57 658.744 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 3.398 192,40 653.788 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 3.413 182,50 622.869 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 3.045 188,26 573.253 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 2.635 180,29 475.071 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 2.587 181,24 468.877 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 2.000 182,49 364.985 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 2.000 181,05 362.107 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 1.900 188,59 358.318 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 1.800 190,63 343.140 $
2026-09-04Chuang Hao-Yuan Chief Financial Officer venda 1.633 180,16 294.201 $
2026-09-04Lin Yu-Hsin Chief Executive Officer venda 600 190,39 114.232 $

Com es llegeixen aquestes operacions

Hi ha 46 operacions declarades de BELITE BIO, INC (BLTE) entre el 2026-09-04 i el 2026-10-01. Les han fetes 3 persones diferents. Compres al mercat: 0, per 0 $. Vendes: 46, per 31.968.735 $.

Cada operació surt d'un Form 4, la declaració que la persona presenta a la SEC. A la taula, cada fila és una operació: la data, qui l'ha feta i el seu càrrec, si és una compra o una venda, el nombre d'accions, el preu per acció declarat i l'import total.

Les compres al mercat són les que més es miren, perquè qui les fa hi posa diners propis. Les vendes diuen menys: sovint responen a impostos, a diversificar o a plans de venda programats amb antelació. Una operació sola tampoc no diu gaire; el que es mira és si se'n repeteixen, de quantes persones i de quin import.

Altres empreses amb operacions de directius

Bumble Inc. (BMBL) · BlackRock 2037 Municipal Target Term Trust (BMN) · Bank of Marin Bancorp (BMRC) · BRISTOL MYERS SQUIBB CO (BMY) · Bionano Genomics, Inc. (BNGO) · BioNTech SE (BNTX) · Bank of New York Mellon Corp (BNY) · Boundless Bio, Inc. (BOLD)

Dades públiques de la SEC (EDGAR), Form 4. Només compres i vendes al mercat: no hi surten els exercicis d'opcions ni les accions rebudes com a sou. No és una recomanació d'inversió.

Segueix-los al costat de la teva cartera

A Arvenyx veus aquestes carteres, les compres dels directius i la teva pròpia cartera, de tots els bròquers, en un sol lloc.

Crea un compte gratuït